Protocol
Sermorelin (10mg Vial)
Complete dosage protocol and reconstitution guide for Sermorelin (10mg Vial).
Calculator preset
Run the vial math before tracking.
At ~3.33 mg/mL, 1 unit ~ 33.3 mcg ; 200 mcg ~ 6 units and 500 mcg ~ 15 units on a U-100 syringe.
01 · At a glance
Quickstart Highlights
Sermorelin is a synthetic growth hormone–releasing hormone (GHRH) analog that stimulates endogenous pituitary GH secretion [1] . Originally approved for pediatric growth hormone deficiency, it is studied for adult off‑label use to support physiologic GH output and IGF‑1 levels [2] . This educational protocol presents a once‑daily subcutaneous approach administered at bedtime to align with natural nocturnal GH release [3] .
02 · Dosing & reconstitution
Dosing & Reconstitution Guide
A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.
Standard / Gradual Approach (3 mL = ~3.33 mg/mL)
200–500 µg once daily at bedtime (gradual titration).
Reconstitution Steps
- Draw 3.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall; gently swirl to dissolve (do not shake vigorously) [2] .
- Label with reconstitution date and refrigerate at 2–8 °C (36–46 °F) , protected from light [2] [4] .
- Wipe vial stopper with alcohol before each use; use a new sterile needle and syringe for each injection [2] .
03 · What you'll need
Supplies Needed
Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.
- 12 weeks (similar daily range): 4 vials Tip: Have 1 extra vial as backup in case of spillage or loss.
- 8 weeks: 56 syringes (recommend 1 × 100‑count box)
- 12 weeks: 84 syringes (1 × 100‑count box) Preferred: 0.3–0.5 mL size with 28G–31G needle, 5/16″ to 1/2″ length for subcutaneous use. Consider 30‑ or 50‑unit syringes for low‑dose weeks for improved precision.
- 8 weeks (2 vials): 6 mL → 1 × 10 mL bottle
- 12 weeks (4 vials): 12 mL → 2 × 10 mL bottles Contains benzyl alcohol preservative; do not use if allergic.
- Per week: 14 swabs (2/day)
- 8 weeks: 112 swabs → recommend 2 × 100‑count boxes
- 12 weeks: 168 swabs → recommend 2 × 100‑count boxes Sharps Container: One puncture‑proof disposal container for used needles (sufficient for 56+ syringes).
Protocol Overview
- Goal: Stimulate endogenous pituitary GH release to support physiologic IGF‑1 levels and anabolic processes [1] [2] .
- Schedule: Daily subcutaneous injections at bedtime for 3–6 months (pediatric trials ran 6–12 months; adult use is off‑label) [1] .
- Dose Range: 200–500 µg daily (adult research range; pediatric: 30 µg/kg nightly) [1] [2] .
- Reconstitution: 3.0 mL per 10 mg vial (~3.33 mg/mL) for accurate unit measurements.
- Storage: Lyophilized refrigerated; reconstituted refrigerated and used within 10–14 days [4] .
Dosing Protocol
- Suggested nightly titration approach for adult off‑label use.
- Start: 200 µg nightly at bedtime; increase by ~100 µg every 1–2 weeks as tolerated.
- Target: 300–500 µg nightly by Weeks 5–8 (adjust based on IGF‑1 response).
- Frequency: Once per day (subcutaneous, preferably before sleep) [3] .
- Cycle Length: 3–6 months typical for adult research use; pediatric trials ran 6–12 months [1] .
- Timing: Bedtime administration leverages natural nocturnal GH pulse; rotate injection sites systematically [7] .
Storage Instructions
- Lyophilized: refrigerate at 2–8 °C (36–46 °F) ; after reconstitution, refrigerate at 2–8 °C (36–46 °F) and use within 10–14 days [4] .
- Storage: Lyophilized refrigerated; reconstituted refrigerated and used within 10–14 days [4] .
- Keep mixed and unmixed items clearly labeled so inventory and dose logs stay accurate.
04 · Good to know
Important Notes
- Practical considerations for consistency, safety, and optimal response.
- Bedtime dosing is critical: Sermorelin works best when administered before sleep to align with the natural nocturnal GH pulse [3] .
- Low-dose precision: For weeks 1–4 (≤10 units), consider using 30‑ or 50‑unit insulin syringes for more precise measurements.
- Use new sterile insulin syringes; dispose in a designated sharps container after each use [7] .
- Rotate injection sites systematically (abdomen, thighs, upper arms) to prevent irritation or lipohypertrophy [7] .
- Inject slowly subcutaneously; wait a few seconds before withdrawing the needle to ensure full delivery.
- Monitor IGF‑1 levels at baseline and periodically (every 1–2 months) to confirm response and adjust dosing if needed.
05 · How it works
How This Works
Sermorelin is a synthetic growth hormone–releasing hormone (GHRH) analog that stimulates endogenous pituitary GH secretion [1] .
Originally approved for pediatric growth hormone deficiency, it is studied for adult off‑label use to support physiologic GH output and IGF‑1 levels [2] .
This educational protocol presents a once‑daily subcutaneous approach administered at bedtime to align with natural nocturnal GH release [3] .
The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.
06 · Daily habits
Lifestyle Factors
- Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
- Track body metrics only if they are relevant to the user's goal and approved data sources.
- Use consistent timing and logging habits so adherence data is meaningful.
07 · What to expect
Potential Benefits & Side Effects
- Sermorelin observations should be recorded conservatively: expected research endpoints, tolerability notes, injection-site reactions when applicable, sleep, appetite, energy, mood, and any adverse or unusual response.
- This section is not a claim of therapeutic benefit.
08 · Technique
Injection Technique
- Wash hands with soap and water.
- Wipe the vial stopper and chosen site with alcohol, then let both dry.
- Confirm the vial concentration, calculator result, and intended draw amount before loading the syringe.
- Use the route and needle technique directed by a qualified professional or product instructions.
- For subcutaneous injections, rotate sites and inject slowly to limit leakage and irritation.
- Do not reuse needles or syringes.
- Dispose of sharps in a puncture-resistant container.
- Return stored items promptly to the correct temperature.
- Log dose, site, date, time, inventory change, and any observation.
09 · Evidence
References
Related pages